Tower Research Capital LLC (Trc) Viking Therapeutics, Inc. Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 9,490 shares of VKTX stock, worth $317,535. This represents 0.02% of its overall portfolio holdings.

Number of Shares

9,490

Previous 20,512 53.73%

Holding current value

$317,535

Previous $1.09 Million 44.8%

% of portfolio

0.02%

Previous 0.02%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$49.84 - $70.47 $549,336 - $776,720	-11,022 Reduced 53.73%	9,490 $600,000
Q2 2024 Aug 13, 2024	BUY	$47.39 - $80.2 $907,802 - $1.54 Million	19,156 Added 1412.68%	20,512 $1.09 Million
Q1 2024 May 15, 2024	SELL	$17.4 - $94.5 $305,109 - $1.66 Million	-17,535 Reduced 92.82%	1,356 $111,000
Q4 2023 Feb 13, 2024	BUY	$9.24 - $19.64 $99,976 - $212,504	10,820 Added 134.06%	18,891 $351,000
Q3 2023 Nov 14, 2023	BUY	$10.92 - $16.0 $57,308 - $83,968	5,248 Added 185.9%	8,071 $89,000
Q2 2023 Aug 14, 2023	SELL	$14.84 - $24.79 $150,626 - $251,618	-10,150 Reduced 78.24%	2,823 $45,000
Q1 2023 May 09, 2023	BUY	$8.08 - $17.33 $75,879 - $162,746	9,391 Added 262.17%	12,973 $216,000
Q4 2022 Feb 10, 2023	BUY	$2.72 - $9.4 $7,980 - $27,579	2,934 Added 452.78%	3,582 $34,000
Q3 2022 Nov 10, 2022	BUY	$2.55 - $3.89 $1,642 - $2,505	644 Added 16100.0%	648 $2,000
Q2 2022 Aug 15, 2022	SELL	$2.11 - $3.15 $58,550 - $87,409	-27,749 Reduced 99.99%	4 $0
Q1 2022 May 12, 2022	SELL	$3.0 - $4.88 $96,003 - $156,164	-32,001 Reduced 53.55%	27,753 $83,000
Q4 2021 Feb 14, 2022	BUY	$4.6 - $6.72 $206,659 - $301,902	44,926 Added 302.98%	59,754 $275,000
Q3 2021 Nov 15, 2021	BUY	$5.58 - $7.04 $56,637 - $71,456	10,150 Added 216.97%	14,828 $94,000
Q2 2021 Aug 16, 2021	SELL	$5.19 - $6.73 $11,148 - $14,456	-2,148 Reduced 31.47%	4,678 $28,000
Q1 2021 May 17, 2021	SELL	$5.74 - $9.67 $23,568 - $39,705	-4,106 Reduced 37.56%	6,826 $43,000
Q4 2020 Feb 16, 2021	BUY	$5.3 - $6.71 $3,625 - $4,589	684 Added 6.67%	10,932 $61,000
Q3 2020 Nov 16, 2020	SELL	$5.73 - $8.11 $58,560 - $82,884	-10,220 Reduced 49.93%	10,248 $60,000
Q2 2020 Aug 13, 2020	BUY	$4.35 - $8.08 $88,600 - $164,573	20,368 Added 20368.0%	20,468 $148,000
Q1 2020 May 15, 2020	SELL	$3.45 - $7.95 $10,732 - $24,732	-3,111 Reduced 96.89%	100 $0
Q4 2019 Feb 07, 2020	SELL	$6.38 - $8.73 $30,560 - $41,816	-4,790 Reduced 59.87%	3,211 $26,000
Q3 2019 Nov 05, 2019	BUY	$6.55 - $8.6 $50,847 - $66,761	7,763 Added 3261.76%	8,001 $55,000
Q2 2019 Aug 13, 2019	BUY	$7.67 - $10.63 $1,825 - $2,529	238 New	238 $2,000
Q1 2019 May 14, 2019	SELL	$7.58 - $9.94 $60 - $79	-8 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$7.16 - $16.21 $57 - $129	8 New	8 $0

Others Institutions Holding VKTX

# of Institutions

470

Shares Held

63.2M

Call Options Held

5.76M

Put Options Held

3.39M

View Full List

About Viking Therapeutics, Inc.

Ticker VKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,688,496
Market Cap $2.57B
Description
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...

More about VKTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Viking Therapeutics, Inc. Transaction History